Delivery Order SPE2DB22D3011-SPE2DB25FQ2BB
- Not listed
- The Defense Logistics Agency awarded a $16,313.49 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $22,965.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency awarded a $2,465.15 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price, non-set-aside contract represents a small-value pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive...
- The Defense Logistics Agency awarded a $19,662.17 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,018.43 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $13,980.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded non-set-aside contract for pharmaceutical supplies to support federal medical procurement needs. The product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $31,043.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 8, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,987.58 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pens on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical supply to federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2BBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pens valued at $17,343.17 with a firm fixed price contract type. This order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver medications, vaccines, and medical supplies to support military healthcare programs worldwide through the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 7/30/25 |